The Asia Pacific Electrophysiology Market would witness market growth of 9.6% CAGR during the forecast period (2022-2028).
Electrophysiology is the study of electrical properties of biological cells & tissues, which includes measurements of electric current or voltage changes on a variety of scales ranging from single ion channel proteins to complete organs such as the heart. Electrophysiology, which is important for electrodiagnosis & monitoring, is based on measurements of the electrical activity of neurons in neuroscience. The potential to target the parts of the heart that cause atrial fibrillation has improved owing to considerable advancements in EP technologies (AF). Electrophysiology devices are used to identify cardiac arrhythmias, which affect half of the population.
Electrophysiology is anticipated to gain significant prominence in the coming years as the prevalence of cardiac arrhythmia continues to rise. Electrophysiology devices with different modalities, such as cardiac computerized tomography (CT), fluoroscopy, cardiac magnetic resonance imaging (CMR), echocardiography, & electro-anatomic mapping, help healthcare professionals analyze the underlying mechanisms of multiple arrhythmia cases quickly.
According to a study published in 2018, "Epidemiology of Atrial Fibrillation - An Indian Perspective," the prevalence of atrial fibrillation in Asia-Pacific countries like India, Australia, New Zealand, Malaysia, South Korea, Singapore, Thailand, & Taiwan to a minimal rate in hospital-based studies, respectively. As per a study published in 2017, "Atrial Fibrillation: The Current pandemic," China's population is plagued by heart strokes to the tune of a small share of the population. The increasing incidence of cardiac disorders is likely to boost the market over the forecast period since electrophysiological devices have a large application in identifying heart failure rates. In addition, a rapid increase in the ageing population has been linked to an increase in heart failure rates, which has contributed to the electrophysiology market's expansion. There are only a few prominent companies in the highly competitive Asia-Pacific electrophysiology market.
The China market dominated the Asia Pacific Electrophysiology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $900.4 million by 2028. The Japan market is estimated to grow at a CAGR of 9% during (2022 - 2028). Additionally, The India market would display a CAGR of 10.3% during (2022 - 2028).
Based on Type, the market is segmented into Electrophysiology Laboratory Devices, Electrophysiology Diagnostic Catheters, Electrophysiology Ablation Catheters, Electrophysiology Access Devices, and Others. Based on Electrophysiology Laboratory Devices Type, the market is segmented into ICE Ultrasound Imaging Systems, Electrophysiology X-Ray Systems, Radiofrequency (RF) Ablation Systems, 3D Mapping Systems & Electrophysiology Recording Systems, and Electrophysiology Remote Magnetic & Robotic Navigation Systems. Based on Electrophysiology Diagnostic Catheters Type, the market is segmented into Conventional, Ultrasound, and Advanced. Based on Electrophysiology Ablation Catheters Type, the market is segmented into Laser, Cryoablation, and Radiofrequency (RF) & Microwave. Based on End User, the market is segmented into Hospitals & Cardiac centres, and Ambulatory Surgery Centers. Based on Indication type, the market is segmented into Atrial Fibrillation, Atrial Flutter, AVNRT & WPW, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Electrophysiology Market is Projected to reach USD 11.9 Billion by 2028, at a CAGR of 8.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, General Electric (GE) Co. (GE Healthcare), Medtronic PLC, Koninklijke Philips N.V., Siemens Healthineers AG, Johnson & Johnson, MicroPort Scientific Corporation, Stereotaxis Inc., and Acutus Medical, Inc.
By Type
By End User
By Indication type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 